Centiva Capital, LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$360,403
-79.4%
19,150
-71.7%
0.01%
-86.6%
Q1 2021$1,746,000
+205.8%
67,674
+533.5%
0.07%
+204.5%
Q4 2020$571,000
+5.2%
10,682
-18.8%
0.02%
-38.9%
Q3 2020$543,000
-2.5%
13,156
+14.5%
0.04%
+5.9%
Q2 2020$557,00011,4940.03%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders